90485-24-8Relevant articles and documents
Development of novel Asf1-H3/H4 inhibitors
Miknis, Greg F.,Stevens, Sarah J.,Smith, Luke E.,Ostrov, David A.,Churchill, Mair E.A.
, p. 963 - 968 (2015)
The histone chaperone anti-silencing function 1 (Asf1) has emerged as a promising target for therapeutic intervention for multiple cancers (Cell 2006, 127, 458). Asf1 is involved in the packaging of the eukaryotic genome into chromatin, which is essential